Current and future therapies for age-related macular degeneration

Medicine and Dentistry

• Age Related Macular Degeneration 100%
• Angiogenesis 33%
• Vasculotropin 33%
• Photochemotherapy 33%
• Choroidal Neovascularization 33%
• Elderly Population 33%
• Programmed Cell Death 33%
• Protein Expression 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Age Related Macular Degeneration 100%
• Inflammation 33%
• Protein 33%
• Photodynamic Therapy 33%
• Subretinal Neovascularization 33%
• Vasculotropin 33%